• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

PhD

Is Education is the Catalyst to Increased Adoption of Handheld Ultrasound?

by Mustafa Hassan, Market Analyst at Signify Research 03/07/2023 Leave a Comment

Education is the Catalyst to Increased Adoption of Handheld Ultrasound

Handheld ultrasound has not yet reached mainstream adoption but the market is still forecast to reach over $500 million by 2026. Signify Research’s newly published Handheld Ultrasound Deep Dive Report 2022 shows that market revenues are estimated to have grown by approximately 30% in 2021, driven by strong growth in the US, the biggest market for handheld ultrasound. Despite the global challenges for handheld ultrasound vendors in 2022, such as rising inflation and supply chain disruptions, the
Read More

U.S. Air Force and SimX Expands VR Medical Training Partnership

by Fred Pennic 02/09/2023 Leave a Comment

U.S. Air Force and SimX Expands VR Medical Training Partnership

What You Should Know: - SimX and the U. S. Air Force are announcing a $1.7M expansion of its ongoing effort to advance the future of medical simulation training using virtual reality (VR) technology. - This effort, housed within the Virtual Advancement of Learning for Operational Readiness (VALOR) program at SimX, aims to enhance the usability and medical capability of virtual simulation training, with a focus on prehospital combat casualty care delivered by the Air Force's elite special
Read More

Why Researchers Should Explore New Apps of Machine Learning

by Michael Munsell, Director of Research at Panalgo 02/08/2023 Leave a Comment

Why Researchers Should Explore New Apps of Machine Learning

As the amount of real-world data (RWD) in the pharmaceutical industry continues to grow, so does the usage of machine learning (ML) to analyze that data and gain insights. In fact, in a recent survey, 95% of life sciences executives said they expect to utilize ML in the next few years to generate real-world evidence (RWE) from this data.  With such a large and growing volume of data available, researchers may be wondering how they can take advantage of all of it to enhance and expand the
Read More

Study Reveals Current Landscape of FHIR Apps

by Syed Hamza Sohail 01/16/2023 Leave a Comment

Study Reveals Current Landscape of FHIR Apps

What You Should Know: - A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how the innovative standard is used to enable the flow of health information - FHIR apps can pull in data from most electronic health record systems, facilitating secure movement of information when and where needed. Expanding the Horizon of Patient Data Security Via FHIR Apps FHIR,
Read More

Trust in Local Hospitals/Health Systems Increased During Pandemic

by Syed Hamza Sohail 12/23/2022 Leave a Comment

Trust in Local Hospitals and Health Systems Increased During the Pandemic

What You Should Know: - NRC Health, the leading partner in building Human Understanding through personalized healthcare solutions and data-driven insights, released findings from its national Market Insights study that reveal that people trust local hospitals and health systems far more than they trust federal, state, and local government to handle the COVID-19 pandemic. - NRC Health also found through its experience surveys that patients’ language preferences are a strong predictor of
Read More

BehaVR & Oxford VR Merge, Raises $13M for VR Delivery Platform

by Fred Pennic 12/13/2022 Leave a Comment

BehaVR & Oxford VR Merge, Raises $13M for VR Delivery Platform

What You Should Know: - Virtual reality mental and behavioral health companies BehaVR and OxfordVR today announced their merger, supported by an initial $13M in Series B funding led by Optum Ventures and Oxford Science Enterprises, with participation from Confluent Health, Accenture Ventures, Chrysalis Ventures and Thornton Capital. - Uniting under the BehaVR brand, digital therapeutic companies BehaVR and OxfordVR will deliver comprehensive virtual reality-based treatments for mental and
Read More

Specialty Pharma’s Next Big Opportunity: It’s Time for Patient Access to Adopt an Open Protocol

by Yishai Knobel, CEO and co-founder of RxWare 12/01/2022 Leave a Comment

Specialty Pharma’s Next Big Opportunity: It’s Time for Patient Access to Adopt an Open Protocol,

In January 2020, the financial conglomerate Visa announced it was acquiring a relatively unknown startup, Plaid, for $5.3 billion. Corporate acquisitions like these are not uncommon, but someone at the United States Department of Justice took notice of this announcement. Visa had established a stranglehold on financial transactions. The Justice Department moved to stop the acquisition on grounds that Plaid posed “a threat to this monopoly: it has been developing an innovative
Read More

ConcertAI Names Ronan Brown as its First COO

by Jasmine Pennic 11/15/2022 Leave a Comment

ConcertAI Names Ronan Brown as its First COO

What You Should Know: - ConcertAI, which provides AI SaaS and real-world data tech solutions for oncology research and trials, today announced the appointment of Ronan Brown as its first COO. - In his new role as COO, Brown will oversee and enhance day-to-day operations across the company, globally, to assure the quality, performance, and seamless functionality of the company’s solutions as the ConcertAI continues it high growth. - Brown, who was most recently senior vice
Read More

Arine, Gemini Health Partner to Optimize Medications While Lowering Prescription Drug Costs

by Jasmine Pennic 10/26/2022 Leave a Comment

Arine, Gemini Health Partner to Optimize Medications While Lowering Prescription Drug Costs

What You Should Know: - Arine - a next-generation medication intelligence company - and Gemini - a drug cost transparency platform - announced an integration that supports Blue Shield of California (Blue Shield) by combining each platform’s unique technology to deliver value-based care. - The collaboration incorporates cost transparency information into Arine’s medication intelligence platform to empower care teams to provide highly personalized, data-driven medication consultations for
Read More

When Advancing a Medical Device, Be A Partner First & Seller Second to Hospital Systems

by Rolland Carlson, CEO of Immunexpress 10/21/2022 Leave a Comment

US hospital systems validate the safety, clinical utility, and robustness of newly FDA-approved devices, 510(k) cleared, before adopting them into clinical practice. This work occurs alongside evaluating how to integrate the medical device into the hospital system’s diagnostic paradigms, including in relation to quality improvement programs. Companies can have a role but there are 415 US hospital systems (comprising ~5,000 hospitals), and each has a bespoke process and ever-changing set of
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 9
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |